These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


278 related items for PubMed ID: 16930249

  • 21. Allergens and allergen immunotherapy. Preface.
    Lockey RF, Ledford DK.
    Clin Allergy Immunol; 2008; 21():vii. PubMed ID: 18828494
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Medication with antihistamines impairs allergen-specific immunotherapy in mice.
    Johansen P, Senti G, Maria Martínez Gómez J, Kündig TM.
    Clin Exp Allergy; 2008 Mar; 38(3):512-9. PubMed ID: 18081882
    [Abstract] [Full Text] [Related]

  • 28. Allergen immunotherapy: what can and cannot be mixed?
    Esch RE.
    J Allergy Clin Immunol; 2008 Sep; 122(3):659-60. PubMed ID: 18774400
    [No Abstract] [Full Text] [Related]

  • 29. Allergen immunotherapy and standardization and stability of allergen extracts.
    Weber RW.
    J Allergy Clin Immunol; 1989 Dec; 84(6 Pt 2):1093-6. PubMed ID: 2600347
    [No Abstract] [Full Text] [Related]

  • 30. Recombinant allergens for immunotherapy.
    Valenta R, Niederberger V.
    J Allergy Clin Immunol; 2007 Apr; 119(4):826-30. PubMed ID: 17335886
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The LOCAL Study: Local reactions do not predict local reactions in allergen immunotherapy.
    Calabria CW, Coop CA, Tankersley MS.
    J Allergy Clin Immunol; 2009 Oct; 124(4):739-44. PubMed ID: 19767075
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Evaluation of allergen vaccine potency.
    Esch RE.
    Curr Allergy Asthma Rep; 2006 Sep; 6(5):402-6. PubMed ID: 16899202
    [Abstract] [Full Text] [Related]

  • 39. Allergen-related approaches to immunotherapy.
    Rolland JM, Gardner LM, O'Hehir RE.
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [Abstract] [Full Text] [Related]

  • 40. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial.
    Senti G, Johansen P, Haug S, Bull C, Gottschaller C, Müller P, Pfister T, Maurer P, Bachmann MF, Graf N, Kündig TM.
    Clin Exp Allergy; 2009 Apr; 39(4):562-70. PubMed ID: 19226280
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.